Creator of deadly cancer vaccine now working on new MRSA shot
Microbiologist, Kathrin Jansen, the woman responsible for developing the infamous Gardasil vaccine for cervical cancer, is back in the laboratory working on a new shot.
Now she is working on a new vaccine for antibiotic-resistant methicillin-resistant Staphylococcus aureus (MRSA) – the hospital superbug.
Race to market
It is likely that it will be a decade before this first MRSA vaccine hits the market but even so the race is on to get it made as quickly as possible. And that in itself raises many questions and concerns.
Results were catastrophic the last few times that experimental vaccines for MRSA were tested in humans.
Organ dysfunction and death
Think back to 2011 and a Merck & Co. trial. The vaccine resulted in such high rates of multi-organ dysfunction and death that the drug giant flat-out cancelled the trial, declaring that the vaccine, known as V710, was “unlikely to show a significant clinical benefit.” At a later meeting of IDWeek 2012, representatives of the vaccine were forced to admit publicly that it had been a complete failure, despite the fact that it produced what they claim was a “robust immunologic response.”
Previous attempts at developing a vaccine for MRSA have been similarly disastrous. But this has not deterred Jansen with pursuing her mission to create her own novel take on a MRSA vaccine.
According to reports, Jansen’s new vaccine targets MRSA from four different angles – something she hopes will prove to be more effective than earlier approaches that targeted the superbug from only one or two angles at most. And she is apparently anxious to begin larger human clinical trials as soon as possible, as competitors like GlaxoSmithKline and Novartis are also working on introducing their own MRSA vaccines in the next few years.
Neurological damage in infants
So what else is on her CV? As well as developing and bringing to market the deadly HPV vaccine Gardasil for drug giant Merck, she also helped develop the $4 billion-a-year multivalent pneumonia and meningitis vaccine Prevnar 13 for Pfizer, which has been linked not only to high rates of neurological damage in infants, but also to a higher rate of infection among those vaccinated compared to those unvaccinated.
Not exactly the best of vaccine safety track records, is it? And yet she is being allowed to push her new MRSA vaccine through the clinical trial system.
Trial involving thousands
“If Pfizer gets the results they hope for, likely later this year, the company expects to meet with regulators to iron out a plan for larger trials involving thousands of individuals,” explains a recent Fox News report.
Isn’t the irony in all of this that MRSA has only emerged as a deadly disease as a direct result of pharmaceutical drugs? And now people like Jansen are trying to create more drugs as a solution.
Staph is nothing new. It has been around for centuries – living n human skin and in human bodies.
But it is only thanks to man-made antibiotics and other drugs that the bacteria has now become deadly. And the answer from Jansen and her like-minded fellow scientists? Search for a natural solution to eliminate MRSA and superbugs? No! Let’s create even more manufactured drugs to supposedly treat them. Drugs which will inevitably do more harm than good.
Would you be willing to be a guinea pig for the trialing of Jansen’s new MRSA vaccine? We think we know the answer to that one!
Let us know your thoughts by posting comments below.
Remember to always consult a licensed healthcare practitioner before embarking on any treatment, it’s your health and it’s IMPORTANT. Disclaimer
If you enjoy reading these articles you might be interested in receiving our monthly newsletter. Read more here
Members don’t forget you can view all past and present Newsletters on the site here